New Cell Study Presents Ground-breaking Pre-Clinical Work: Developing Immune Therapy to Potentially Treat Serious Influenza A
MEDI8852 blocked all influenza A with unique binding properties
MEDI8852 blocked all influenza A with unique binding properties
Functionalized gold nanoparticles for easy, fast covalent conjugation of antibodies
Dr Nune Darbinian discusses latest research findings at Shriners Hospitals Pediatric Research Center
Dr Ben Prosser discusses his mechanobiology research, recently published in Science
In-depth profiling of IgG glycosylation coupled with ADCC assays enables generation of robust biosimilar comparability data
Acquisition expands portfolio of Lab Products & Services division, incorporating unique technology for cell analysis in biopharma applications
SelectScience® spoke to Rebecca Gentile, Senior Specialist in Quality, Vaccine and Biological Stability at Merck, about the future and current challenges of her work
Project that measured pathogens in New York City subways goes global this summer
Watch interviews from industry experts at this year’s American Association of Cancer Research (AACR) Annual Meeting
New application study demonstrates the plasma protein analyzing abilities of Postnova Analytics’ AF4-ICP-MS system
Read highlights from this indispensable webinar
Dr Tony Ludlam, Protein Core Manager, Cayman Chemical, tells SelectScience® about the technology improving protein production
Studies demonstrate pioneering research possible using ChIP technology
Afucosylation can enable more precise assessment of allergic sensitization
BioPorto offer customizable lateral flow assays distributed by Alpha Laboratories
Discover the benefits of new technology and method development strategies for new techniques
Company aims to help accelerate progress toward a vaccine or treatment for this global health threat